JSSH
MREO

J. Safra Sarasin Holding’s Mereo BioPharma MREO Stock Holding History

J. Safra Sarasin Holding’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.08K Buy
+12,841
New +$3.85K ﹤0.01% 799

Other funds holding MREO

SWP
Significant Wealth Partners Cary, Illinois $92.4M AUM 9.22% 1-Year Est. Return
APA
Astoria Portfolio Advisors New York $593M AUM 28.97% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
NECFA
New England Capital Financial Advisors Meriden, Connecticut $418M AUM 16.7% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

J. Safra Sarasin Holding's MREO Position: Q2 2026 in Review

J. Safra Sarasin Holding opened a new position in Mereo BioPharma (MREO) in Q2 2026: 12,841 shares worth $4.08K. The stake represents ﹤0.01% of the portfolio and ranks #799 among its holdings.

9 funds tracked by Wall St. Rank hold MREO as of Q2 2026.

  • J. Safra Sarasin Holding held 12,841 shares of Mereo BioPharma worth $4.08K as of Q2 2026.
  • Mereo BioPharma was a new J. Safra Sarasin Holding position in Q2 2026.
  • Mereo BioPharma made up ﹤0.01% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #799 holding.
  • 9 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.